Zim Laboratories (NSE:ZIMLAB) Cash-to-Debt: N/A (As of Jun. 2026)

Zim Laboratories  (NSE:ZIMLAB) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Zim Laboratories Cash-to-Debt Related Terms

The historical data trend for Zim Laboratories's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Zim Laboratories Cash-to-Debt Chart

Zim Laboratories Annual Data
	Trend	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24	Mar25	Mar26
Cash-to-Debt		Get a 7-Day Free Trial					0.06	0.10	0.09	0.02	0.22

Zim Laboratories Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
Cash-to-Debt	Get a 7-Day Free Trial															N/A	0.04	N/A	0.22	N/A

NSE:ZIMLAB vs ZTS: Cash-to-Debt Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zim Laboratories's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zim Laboratories Cash-to-Debt vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zim Laboratories's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Zim Laboratories's Cash-to-Debt falls into.

Zim Laboratories Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Zim Laboratories's Cash to Debt Ratio for the fiscal year that ended in Mar. 2026 is calculated as:

Zim Laboratories's Cash to Debt Ratio for the quarter that ended in Jun. 2026 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zim Laboratories Business Description